---
title: Brolucizumab and Platelet Activation and Reactivity
date: '2025-01-06'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39760267/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250106171058&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: Brolucizumab does not appear to directly affect platelet
  activation or reactivity to thrombin receptor agonists. No platelet interaction
  was observed after increasing brolucizumab concentrations or anti-brolucizumab antibodies
  in resting and activated platelets. However, brolucizumab might be taken up in ...'
disable_comments: true
---
CONCLUSION: Brolucizumab does not appear to directly affect platelet activation or reactivity to thrombin receptor agonists. No platelet interaction was observed after increasing brolucizumab concentrations or anti-brolucizumab antibodies in resting and activated platelets. However, brolucizumab might be taken up in ...